Showing 31-40 of 1572 results for "".
Stem cells to regenerate the heart
https://reachmd.com/programs/clinicians-roundtable/stem-cells-to-regenerate-the-heart/2490/A treatment that uses adult stem cells to rebuild failing hearts - once believed to be impossible - is making progress helping patients rebound from severe coronary artery disease, a leading killer of people around the world. Dr. Douglas Losordo, head of the program in cardiovascular regenerative meParsing the Debate Over Embryonic Stem Cells
https://reachmd.com/programs/clinicians-roundtable/parsing-the-debate-over-embryonic-stem-cells/2972/While politicians debate whether there should be federal funding of embryonic stem cells, they might be over-looking a key point: the fact that all of the momentum in stem cell research is not in cells derived from human embryos at all. Randal Mills, the chief executive officer of Osiris TherapeuticStem Cell Research: The Mouse Incisor Model
https://reachmd.com/programs/clinicians-roundtable/stem-cell-research-the-mouse-incisor-model/2896/Where do we stand with stem cell research, and what does the future hold for this controversial field of investigation? Host Dr. Bruce Bloom discusses stem cell research with Dr. Ophir Klein, of the Biomedical Sciences Graduate Program at the University of California, San Francisco.Stem Cell Therapy: A Major Regulatory Milestone
https://reachmd.com/programs/clinicians-roundtable/stem-cell-therapy-a-major-regulatory-milestone/2973/2008 was a watershed year for stem cell-based treatment, with the first product of this kind going before an FDA review for approval. Learn more from Randal Mills, PhD, chief executive officer of Osiris Therapeutics, as he unveils details of his company’s stem cell-based medicine with host Bruce JapNew Frontiers in Embryonic Stem Cell Research
https://reachmd.com/programs/clinicians-roundtable/new-frontiers-in-embryonic-stem-cell-research/4592/President Obama expanded federal funding for certain embryonic stem cell research and many are excited about what it means to the entire field of discovery of new drugs and medical treatments. Linda Powers, of the Maryland Stem Cell Commission, tells host Bruce Japsen about the importance of Obama'sFederal Funding Controversies and Stem Cell Research
https://reachmd.com/programs/clinicians-roundtable/federal-funding-controversies-and-stem-cell-research/4467/The highly publicized decision by President Obama to add more federal dollars toward embryonic stem cell research may be fueling misconceptions about how drugs and medical products are created. But it's a part of the debate on stem cells that some in medicine think needs to be heard. Dr. Scott GottlA Successful and Safe Stem Cell Therapy for Progressive MS
https://reachmd.com/programs/neurofrontiers/a-successful-and-safe-stem-cell-therapy-for-progressive-ms/17928/Dive into the phase 1 study that was successful in showing stem cell therapy for people with active and nonactive progressive MS is doable.Stem Cell Therapy for Neuropathic Trigeminal Pain
https://reachmd.com/programs/world-medical-news/stem-cell-therapy-neuropathic-trigeminal-pain/7407/A group of researchers in Australia have developed a potential means of treating human neuropathic pain with stem cell injections. Dr. Leuchars elaborates.Embryonic stem cell research chances
https://reachmd.com/programs/clinicians-roundtable/embryonic-stem-cell-research-chances/1588/As political pressure builds on Republicans over the War in Iraq, will Congress finally OK a veto-proof bill to allow federal funding for embryonic stem cell research? Mary Woolley, CEO of Research America says the political climate is improving for a bill to pass and survive a Bush veto for embryonDeveloping Lines of RBCs From Stem Cells
https://reachmd.com/programs/focus-on-future-medicine-and-genetics/developing-lines-of-rbcs-from-stem-cells/4137/Scientists and medical experts hold grand ambitions for the emerging role of human embryonic stem cells in medicine. One of the first gains realized from these cells could be the production of red blood cells for transfusion, though several key obstacles remain. Host Dr. Mark Nolan Hill looks at the